Another study revealed, that the assessment of anti-citrulinated peptide antibodies (ACPA) and the RF-IgA together with IgM-RF had no advantage, in regard to the specifity and senitivity in diagnosing RA, than the assesment of RF-IgM only [16]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.